Saturna Capital Corp Abb Vie Inc. Transaction History

Saturna Capital Corp

$7.5 Billion
Q3 2024

A detailed history of Saturna Capital Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Saturna Capital Corp holds 676,176 shares of ABBV stock, worth $122 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares

676,176

Previous 115,368 486.1%

Holding current value

$122 Million

Previous $19.8 Million 574.84%

% of portfolio

1.78%

Previous 0.27%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$163.84 - $199.33 $91.9 Million - $112 Million	560,808 Added 486.1%	676,176 $134 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $95,892 - $109,260	600 Added 0.52%	115,368 $21 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $178,880 - $201,461	1,300 Added 1.15%	114,768 $17.8 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $3,339 - $3,866	25 Added 0.02%	113,468 $16.9 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $245,143 - $305,065	1,850 Added 1.66%	113,443 $15.3 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $6.44 Million - $7.42 Million	-44,548 Reduced 28.53%	111,593 $17.8 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $17,288 - $20,733	-125 Reduced 0.08%	156,141 $25.2 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $5.33 Million - $6.11 Million	-39,705 Reduced 20.26%	156,266 $21 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $23.4 Million - $29.7 Million	-169,930 Reduced 46.44%	195,971 $30 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $52,791 - $65,500	400 Added 0.11%	365,901 $59.3 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $17,833 - $22,564	-166 Reduced 0.05%	365,501 $49.8 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $21,252 - $23,676	-202 Reduced 0.06%	365,667 $41.2 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $3,154 - $4,221	43 Added 0.01%	365,869 $35.9 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $41,925 - $63,563	-650 Reduced 0.18%	365,826 $27.9 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $288,520 - $361,000	-4,000 Reduced 1.08%	366,476 $32.4 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $1.95 Million - $2.35 Million	-31,000 Reduced 7.72%	370,476 $28.1 Million
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $335,201 - $428,465	-5,102 Reduced 1.25%	401,476 $29.2 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $77 - $90	1 Added 0.0%	406,578 $32.8 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $77,850 - $96,010	-1,000 Reduced 0.25%	406,577 $37.5 Million
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $2.63 Million - $3.11 Million	29,299 Added 7.75%	407,577 $37.8 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $55,206 - $73,926	-600 Reduced 0.16%	378,278 $35.8 Million
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $53,915 - $59,122	602 Added 0.16%	378,878 $36.6 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $13,969 - $17,844	200 Added 0.05%	378,276 $33.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	378,076	378,076 $27.4 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Abb Vie Inc. Transaction History